Company Description
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products.
The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals.
Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.
The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand.
It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States.
The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019.
cbdMD, Inc. is headquartered in Charlotte, North Carolina.
| Country | United States |
| Founded | 2015 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 52 |
| CEO | T. Kennedy |
Contact Details
Address: 8845 Red Oak Boulevard Charlotte, North Carolina 28217 United States | |
| Phone | 704 445 3060 |
| Website | cbdmd.com |
Stock Details
| Ticker Symbol | YCBD |
| Exchange | NYSEAMERICAN |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001644903 |
| CUSIP Number | 12482W101 |
| ISIN Number | US12482W3097 |
| Employer ID | 47-3414576 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| T. Ronan Kennedy | Interim Chief Executive Officer, Chief Financial Officer and Principal Executive Officer |
| Dr. Sibyl Swift Ph.D. | CSO, Vice President of Regulatory Affairs and Director |
| Bradley Whitford | Chief Accounting Officer, Treasurer and Secretary |
| Zeb Booker | Chief Technology Officer |
| Lance Blundell | General Counsel |
| Robert Pettway | Director of Public Relations |
| Francisco Mangual | Senior Vice President of Sales |
| Shannon Charles | Chief Marketing Officer |
| David Johnson | Senior Vice President of Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 30, 2024 | 8-K/A | [Amend] Current report |
| Aug 29, 2024 | 8-K | Current Report |
| Aug 26, 2024 | 8-K | Current Report |
| Aug 19, 2024 | 8-K/A | [Amend] Current report |
| Aug 15, 2024 | 8-K | Current Report |
| Aug 14, 2024 | 10-Q | Quarterly Report |
| Jul 19, 2024 | 8-K | Current Report |
| Jul 16, 2024 | 8-K | Current Report |
| Jun 10, 2024 | 8-K | Current Report |
| May 15, 2024 | 10-Q | Quarterly Report |